Clinical Trial Update: Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) Patients

View source ↗

Summary

This clinical trial update assesses the impact of disease-modifying therapies and associated support services on patients with Relapsing Multiple Sclerosis, bas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Relapsing Multiple Sclerosis | Status: COMPLETED